The Completeness of Cytoreduction (CC) Score is a surgical grading system used to describe how much visible tumor remains in the abdomen after cytoreductive surgery. Surgeons assign a score from CC-0 (no visible tumor left) to CC-3 (nodules larger than 2.5 cm remaining). The score is recorded at the end of the operation and is one of the strongest predictors of long-term outcome in peritoneal mesothelioma.
Origin
The CC Score was developed by Dr. Paul Sugarbaker in the 1990s at the Washington Cancer Institute as part of his framework for treating peritoneal surface malignancies with cytoreductive surgery combined with HIPEC (heated intraperitoneal chemotherapy). It was designed to standardize how surgeons reported residual disease across institutions and clinical trials.
Significance in Asbestos Context
For patients with peritoneal mesothelioma, the form of asbestos-caused cancer that grows on the lining of the abdomen, the CC Score is one of the most important numbers in the operative report. Patients who achieve CC-0 or CC-1 (no visible tumor, or only nodules smaller than 2.5 mm) typically have substantially longer survival after CRS/HIPEC than those with CC-2 or CC-3 results. The score also helps oncologists decide on next steps, such as whether HIPEC will be effective (it generally only penetrates a few millimeters, so it works best after CC-0/CC-1 reduction) and whether systemic chemotherapy should follow. In a legal claim, the CC Score in the operative report documents the extent of disease and the aggressiveness of treatment, which supports damages related to pain, suffering, medical expenses, and shortened life expectancy.
Example Sentence
After her cytoreductive surgery for peritoneal mesothelioma, the operative report noted a CC-1 score, which her oncologist explained was an excellent surgical result and made her a good candidate for HIPEC.
Related Terms
Peritoneal Mesothelioma, Cytoreductive Surgery (CRS), HIPEC, Peritoneal Cancer Index (PCI), Sugarbaker Procedure
Notes
- Ask your surgeon for a copy of the operative report and look for the CC Score and the Peritoneal Cancer Index (PCI). Both numbers are routinely recorded and matter for prognosis and for your legal case.
- If you are considering CRS/HIPEC, ask the surgical team how often they achieve CC-0 or CC-1 for peritoneal mesothelioma patients; outcomes are strongly tied to surgeon and center experience.
- Preserve all operative reports, pathology reports, and pre-operative imaging (CT, MRI, PET). These documents establish disease extent and treatment intensity for both medical follow-up and any compensation claim.
- The CC Score reflects what the surgeon can see; microscopic disease may remain even at CC-0, which is why HIPEC or follow-up chemotherapy is often given alongside surgery.
In the research library
7 studies in our medical research library mention Completeness of Cytoreduction (CC) Score in the title or abstract. Among the most cited:
- A novel nomogram for peritoneal mesothelioma predicts survivalN.P. Schaub, M. Alimchandani, M. Quezado, et al, 2013 · Annals of Surgical Oncology · cited 42 times
- Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosisY. Huang, N.A. Alzahrani, W. Liauw, et al, 2017 · ANZ Journal of Surgery · cited 11 times
- Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal ChemotherapyD.R. Heller, C. Chiuzan, R.N. Taub, et al, 2017 · Annals of Surgical Oncology · cited 9 times
- Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 casesH.L. Wu, Z.R. Yang, Y.D. Su, et al, 2022 · World Journal of Surgical Oncology · cited 8 times
- Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal MesotheliomaY. Chen, X. Du, Y. Gao, et al, 2023 · Cancer Control · cited 3 times
The journals that publish most on it: World Journal of Surgical Oncology (2), Annals of Surgical Oncology (2), Annals of Diagnostic Pathology (1).
Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.